Filipczak, N., Pan, J., Yalamarty, S., & Torchilin, V. P. (2020).\u00a0Recent advancements in liposome technology.<\/a>\u00a0Advanced drug delivery reviews<\/em>,\u00a0156<\/em>, 4\u201322.\u00a0\u00a0<\/p>\n Crommelin, D., van Hoogevest, P., & Storm, G. (2020).\u00a0The role of liposomes in clinical nanomedicine development. What now? Now what?<\/a>.\u00a0Journal of controlled release : official journal of the Controlled Release Society<\/em>,\u00a0318<\/em>, 256\u2013263.\u00a0\u00a0<\/p>\n DeFelice SL.\u00a0The nutraceutical revolution: its impact on food industry R&D<\/a>. Trends Food Sci Technol 1995; 6: 59\u201361.<\/p>\n Santini, A., Cammarata, S. M., Capone, G., Ianaro, A., Tenore, G. C., Pani, L., & Novellino, E. (2018).\u00a0Nutraceuticals: opening the debate for a regulatory framework.<\/a>\u00a0British journal of clinical pharmacology<\/em>,\u00a084<\/em>(4), 659\u2013672.\u00a0<\/p>\n Porter, C,J,, Trevaskis, N.L., Charman, W.N. (2007).\u00a0Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs.<\/a>\u00a0Nature Reviews Drug Discovery 6(3), 231-48.<\/p>\n Detopoulou, P., Panagiotakos, D. B., Antonopoulou, S., Pitsavos, C., & Stefanadis, C. (2008).\u00a0Dietary choline and betaine intakes in relation to concentrations of inflammatory markers in healthy adults: the ATTICA study.<\/a>\u00a0The American journal of clinical nutrition<\/em>,\u00a087<\/em>(2), 424-430.<\/p>\n Ehehalt, R., Wagenblast, J., Erben, G., Lehmann, W. D., Hinz, U., Merle, U., & Stremmel, W. (2004).\u00a0Phosphatidylcholine and lysophosphatidylcholine in intestinal mucus of ulcerative colitis patients. A quantitative approach by nanoelectrospray\u2010tandem mass spectrometry.<\/a>\u00a0Scandinavian journal of gastroenterology<\/em>,\u00a039<\/em>(8), 737-742.<\/p>\n Braun, A., Treede, I., Gotthardt, D., Tietje, A., Zahn, A., Ruhwald, R., Schoenfeld, U., Welsch, T., Kienle, P., Erben, G., Lehmann, W.D., Fuellekrug, J., Stremmel, W., Ehehalt, R. (2009).\u00a0Alterations of phospholipid concentration and species composition of the intestinal mucus barrier in ulcerative colitis: a clue to pathogenesis.<\/a>\u00a0Inflammatory Bowel Diseases,<\/em>\u00a015<\/em>(11), 1705-1720.<\/p>\n Stremmel, W., Merle, U., Zahn, A., Autschbach, F., Hinz, U., Ehehalt, R. (2005).\u00a0Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis.<\/a>\u00a0Gut, 54<\/em>(7), 966-971.<\/p>\n Stremmel, W., Ehehalt, R., Autschbach, F., Karner, M. (2007).\u00a0Phosphatidylcholine for steroid-refractory chronic ulcerative colitis: a randomized trial.<\/a>\u00a0Annals of Internal Medicine, 147<\/em>(9), 603-610.<\/p>\n Stremmel, W., Braun, A., Hanemann, A., Ehehalt, R., Autschbach, F., Karner, M. (2010).\u00a0Delayed release phosphatidylcholine in chronic-active ulcerative colitis: a randomized, double-blinded, dose finding study.<\/a>\u00a0Journal of Clinical Gastroenterology, 44<\/em>(5), e101-e107.<\/p>\n Karner, M., Kocjan, A., Stein, J., Schreiber, S., von Boyen, G., Uebel, P., Schmidt, C., Kupcinskas, L., Dina, I., Zuelch, F., Keilhauer, G., Stremmel, W. (2014).\u00a0First multicenter study of modified release phosphatidylcholine \u201cLT-02\u201d in ulcerative colitis: a randomized, placebo-controlled trial in mesalazine-refractory courses<\/a>.\u00a0American Journal of Gastroenterology, 109<\/em>(7), 1041-1051.<\/p>\n Li, Z., Agellon, L.B., Allen, T.M., Umeda, M., Jewell, L., Mason, A., Vance, D.E. (2006).\u00a0The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis.<\/a>\u00a0Cell Metabolism, 3<\/em>(5), 321-31.<\/p>\n Puri, P., Baillie, R.A., Wiest, M.M., Mirshahi, F., Choudhury, J., Cheung, O., Sargeant, C., Contos, M.J., Sanyal, A.J. (2007).\u00a0A lipidomic analysis of nonalcoholic fatty liver disease.<\/a>\u00a0Hepatology, 46<\/em>(4), 1081-1090.<\/p>\n Nicolson, G. L., & Ash, M. E. (2017).\u00a0Membrane Lipid Replacement for chronic illnesses, aging and cancer using oral glycerolphospholipid formulations with fructooligosaccharides to restore phospholipid function in cellular membranes, organelles, cells and tissues.\u00a0<\/a>Biochimica et Biophysica Acta (BBA)-Biomembranes<\/em>,\u00a01859<\/em>(9), 1704-1724.<\/p>\n Hirose, A., Terauchi, M, Osaka, Y., Akiyoshi, M., Kato, K., Miyasaka, N. (2018).\u00a0Effect of soy lecithin on fatigue and menopausal symptoms in middle-aged women: a randomized, double-blind, placebo-controlled study.<\/a>\u00a0Nutrition Journal, 17<\/em>(1), 1-8.\u00a0<\/p>\n Lieber, C.S., Robins, S.J., Li, J., DeCarli, L.M., Mak, K.M., Fasulo, J.M., Leo, M.A. (1994).\u00a0Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon.\u00a0<\/a>Gastroenterology, 106<\/em>(1), 152-159.<\/p>\n Poly, C., Massaro, J.M., Seshadri, S., Wolf, P.A., Cho, E., Krall, E., Jacques, P.F., Au, R. (2011).\u00a0The relation of dietary choline to cognitive performance and white-matter hyperintensity in the Framingham Offspring Cohort.<\/a>\u00a0The American Journal of Clinical Nutrition, 94<\/em>(6), 1584-1591.\u00a0<\/p>\n Suzuki, S., Yamatoya, H., Sakai, M., Kataoka, A., Furushiro, M., Kudo, S. (2001).\u00a0Oral administration of soybean lecithin transphosphatidylated phosphatidylserine improves memory impairment in aged rats.<\/a>\u00a0The Journal of Nutrition, 131<\/em>(11), 2951-2956.<\/p>\n Lee, B., Sur, B.J., Han, J.J., Shim, I., Her, S., Lee, Y.S., Lee, H.J., Hahm, D.H. (2015).\u00a0Oral administration of squid lecithin-transphosphatidylated phosphatidylserine improves memory impairment in aged rats.<\/a>\u00a0Progress in Neuro-psychopharmacology and Biological Psychiatry, 56<\/em>, 1-10.<\/p>\n Zhou, M.M., Xue, Y., Sun, S.H., Wen, M., Li, Z.J., Xu, J., Wang, J.F., Yanagita, T., Wang, Y.M., Xue, C.H. (2016).\u00a0Effects of different fatty acids composition of phosphatidylcholine on brain function of dementia mice induced by scopolamine.<\/a>\u00a0Lipids in Health and Disease, 15<\/em>(1), 1-10.\u00a0<\/p>\n K\u00fcllenberg, D., Taylor, L.A., Schneider, M., Massing, U. (2012).\u00a0Health effects of dietary phospholipids.<\/a>\u00a0Lipids in Health and Disease, 11<\/em>(1), 1-16.<\/p>\n Additional liposome studies<\/p>\n Liposome technology<\/p>\n Akbarzadeh, A., Rezaei-Sadabady, R., Davaran, S., Joo, S.W., Zarghami, N., Hanifehpour, Y., Samiei, M., Kouhi, M., Nejati-Koshki, K. (2013).\u00a0Liposome: classification, preparation, and applications<\/a>.\u00a0Nanoscale Research Letters 8(1)<\/em>, 102. doi: 10.1186\/1556-276X-8-102.<\/p>\n Briuglia, M.L., Rotella, C., McFarlane, A., Lamprou, D.A. (2015).\u00a0Influence of cholesterol on liposome stability and on in vitro drug release.<\/a>\u00a0Drug Delivery and Translational Research 5(3)<\/em>, 231-42. doi: 10.1007\/s13346-015-0220-8.<\/p>\n Chen, W., Zou, M., Ma, X., Lv, R., Ding, T., Liu, D. (2019).\u00a0Co-Encapsulation of EGCG and Quercetin in Liposomes for Optimum Antioxidant Activity.<\/a>\u00a0Journal of Food Science 84(1)<\/em>, 111-120. doi: 10.1111\/1750-3841.14405.<\/p>\n Kraft, J.C., Freeling, J.P., Wang, Z., & Ho R.J.Y. (2014).\u00a0Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems.<\/a>\u00a0Journal of Pharmaceutical Sciences 103(1)<\/em>, 29\u201352.<\/p>\n Bioavailability of active compounds<\/p>\n Martinez, M.N., Amidon, G.L. (2002).\u00a0A mechanistic approach to understanding the factors affecting drug absorption: a review of fundamentals.<\/a>\u00a0Journal of Clinical Pharmacology 42(6)<\/em>, 620-43.<\/p>\n Takahashi, M., Uechi, S., Takara, K., Asikin, Y., & Wada, K. (2009).\u00a0Evaluation of an Oral Carrier System in Rats: Bioavailability and Antioxidant Properties of Liposome-Encapsulated Curcumin.<\/a>\u00a0Journal of Agricultural and Food Chemistry 57(19)<\/em>, 9141\u20139146.<\/p>\n Wajda, R., Zirkel, J., Schaffer, T. (2007).\u00a0Increase of bioavailability of coenzyme Q(10) and vitamin E.\u00a0<\/a>Journal of Medicinal Food 10(4)<\/em>, 731-4.<\/p>\n DHA<\/p>\n Sun, G. Y., Simonyi, A., Fritsche, K. L., Chuang, D. Y., Hannink, M., Gu, Z., Greenlief, C. M., Yao, J. K., Lee, J. C., & Beversdorf, D. Q. (2018).\u00a0Docosahexaenoic acid (DHA): An essential nutrient and a nutraceutical for brain health and diseases.<\/a>\u00a0Prostaglandins, leukotrienes, and essential fatty acids 136,<\/em>\u00a03\u201313. doi: 10.1016\/j.plefa.2017.03.006.<\/p>\n Weiser, M. J., Butt, C. M., & Mohajeri, M. H. (2016).\u00a0Docosahexaenoic Acid and Cognition throughout the Lifespan.<\/a>\u00a0Nutrients 8(2)<\/em>, 99. doi: 10.3390\/nu8020099.<\/p>\n PEA<\/p>\n Davis, M. P., Behm, B., Mehta, Z., & Fernandez, C. (2019).\u00a0The Potential Benefits of Palmitoylethanolamide in Palliation: A Qualitative Systematic Review.<\/a>\u00a0The American journal of hospice & palliative care 36(12)<\/em>, 1134\u20131154. doi: 10.1177\/1049909119850807.<\/p>\n Mattace Raso, G., Russo, R., Calignano, A., & Meli, R. (2014).\u00a0Palmitoylethanolamide in CNS health and disease.<\/a>\u00a0Pharmacological research 86<\/em>, 32\u201341. doi: 10.1016\/j.phrs.2014.05.006.<\/p>\n Lutein<\/p>\n Mares J. (2016).\u00a0Lutein and Zeaxanthin Isomers in Eye Health and Disease.<\/a>\u00a0Annual review of nutrition 36<\/em>, 571\u2013602. doi: 10.1146\/annurev-nutr-071715-051110.<\/p>\n Ranard, K. M., Jeon, S., Mohn, E. S., Griffiths, J. C., Johnson, E. J., & Erdman, J. W., Jr (2017).\u00a0Dietary guidance for lutein: consideration for intake recommendations is scientifically supported.<\/a>\u00a0European journal of nutrition, 56(Suppl 3),<\/em>\u00a037\u201342. doi: 10.1007\/s00394-017-1580-2.<\/p>\n Melatonin<\/p>\n Andersen, L. P., Werner, M. U., Rosenkilde, M. M., Harps\u00f8e, N. G., Fuglsang, H., Rosenberg, J., & G\u00f6genur, I. (2016).\u00a0Pharmacokinetics of oral and intravenous melatonin in healthy volunteers.<\/a>\u00a0BMC pharmacology & toxicology 17<\/em>, 8. doi: 10.1186\/s40360-016-0052-2.<\/p>\n Meng, X., Li, Y., Li, S., Zhou, Y., Gan, R. Y., Xu, D. P., & Li, H. B. (2017).\u00a0Dietary Sources and Bioactivities of Melatonin.<\/a>\u00a0Nutrients 9(4)<\/em>, 367. doi: 10.3390\/nu9040367<\/p>\n CBD<\/p>\n Fraguas-S\u00e1nchez, A. I., & Torres-Su\u00e1rez, A. I. (2018).\u00a0Medical Use of Cannabinoids<\/a>.\u00a0Drugs 78(16)<\/em>, 1665\u20131703. doi: 10.1007\/s40265-018-0996-1.<\/p>\n Lucas, C. J., Galettis, P., & Schneider, J. (2018).\u00a0The pharmacokinetics and the pharmacodynamics of cannabinoids.<\/a>\u00a0British journal of clinical pharmacology 84(11)<\/em>, 2477\u20132482. doi: 10.1111\/bcp.13710.<\/p>\n